View profile

FarmaKology Newsletter - Issue #6

Would you like to submit an article, some interesting news, or get your startup featured? Send whatev


April 15 · Issue #6 · View online
FarmaKology is a newsletter that brings you the latest news, research, job opportunities in the Pharma world, and much more! If you would like to be featured in the newsletter, sponsor an issue, or need anything, please feel free to get in touch with me at "".

Would you like to submit an article, some interesting news, or get your startup featured? Send whatever you have to “”, and happy to have you featured on our newsletter!

Today's Startup
Perlara is a scientific discovery public benefit corporation that works with families, advocacy groups and BioPharma companies to develop cures for rare diseases.
The US-based Antibacterial Resistance Leadership Group (ARLG), part of the Duke Clinical Research Institute (DCRI) and the University Medical Center (UMC) Utrecht, the managing entity of the COMBACTE (Combatting Bacterial Resistance in Europe) consortium, will work together to solidify a comprehensive global community to combat the threat of antibiotic resistance around the world.
GenScript Biotech Corp, a leading Chinese bio-pharmaceutical contract development and manufacturing organization (CDMO), held the groundbreaking ceremony for the start of construction of the GenScript-Legend Biotech Commercial Manufacturing Center.
Mackay Shields LLC lessened its stake in shares of Diplomat Pharmacy Inc by 59.7% during the fourth quarter, according to its most recent disclosure with the Securities and Exchange Commission .
Canadian company Aurora Cannabis, the world’s second-largest cannabis company, predicts that the expected opening up of the medicinal market may see up to 50,000 Irish patients being prescribed cannabis within four years.
Time running out to find a new breed of antibiotics - 4BC Drive with Mark Braybrook -
Job Opportunities
The pharmacy of the future? Personalized pills, 3D printed at home | Daniel Kraft
Did you enjoy this issue?
If you don't want these updates anymore, please unsubscribe here.
If you were forwarded this newsletter and you like it, you can subscribe here.
Powered by Revue